Ahmedabad (Gujarat) [India], February 24: Gujarat primarily based Vivanza Biosciences Ltd (BSE – 530057) – engaged in the enterprise of prescription drugs and agro buying and selling has reported glorious monetary outcomes for the 9 months ended December 2023. Firm reported consolidated whole revenue of Rs. 23.49 crore for the 9MFY24 with a 137% Y-o-Y progress as in contrast to whole revenue of Rs. 9.92 crore in 9 months of FY23. Net revenue of the corporate additionally jumped 37% to Rs. 96.13 lakh throughout 9MFY24 as in contrast to web revenue of Rs. 70.19 crore.

Firm has reported robust progress over years with 3 12 months CAGR of 23% gross sales and 69% in Net income. Going ahead, the corporate goals to fortify its place by strategically increasing its operations, bolstering manufacturing capabilities, and optimizing organizational capacities. The Firm is totally different alternatives in untapped markets and likewise throughout a worth chain. Additional, the Firm has additionally set its imaginative and prescient in world market to provide and execute turnkey pharmaceutical items and plans for alliances with enterprise associates in the worldwide market

Vivanza Biosciences Restricted is a specialty pharmaceutical firm centered on commercializing novel and generic prescription drugs, providing sufferers higher, secure and more accessible medicines. During the last twenty years, it has carved for itself, alternatives & confronted challenges head on to obtain many milestones. Firm presents diversified product portfolio in therapeutic areas together with Diabetes, Anti Malaria, Nephrology and Cardiovascular. Firm has 100 plus contract manufacturing purchasers and 32 plus merchandise in pipeline. For FY23, firm reported web revenue of Rs. 71.6 lakh and Total revenue of Rs. 18.3 crore.

Earlier in March 2023, firm authorized inventory break up in the ration of 1:10. Firm authorized subdivision of one Fairness Share having face worth of Rs.10 every into 10 Fairness Shares of Rs. 1 every.

The corporate has additional taken main initiatives like robust advertising and marketing efforts, deal with price discount by way of stock administration methods, introduction of new merchandise and manufacturing course of with out compromising high quality of merchandise and retain proficient staff and so forth.

When you have any objection to this press launch content material, kindly contact pr.error.rectification@gmail.com to notify us. We are going to reply and rectify the state of affairs in the following 24 hours.